GoPro, Inc. (NASDAQ:GPRO) announced that it will release its financial results for the fourth quarter and fiscal year 2014, ended December 31, 2014, after the market closes on February 5, 2015. On Friday shares of GoPro, Inc. (NASDAQ:GPRO) closed at $47.51. Company’s EPS growth for next 5 years is recorded as 35.30%.
National Bank of Greece (ADR) (NYSE:NBG) was the recipient of a significant growth in short interest in December. As of December 31st, there was short interest totalling 16,019,769 shares, a growth of 26.0% from the December 15th total of 12,713,533 shares. National Bank of Greece (ADR) (NYSE:NBG) in last trading activity fell -2.92% to close at $1.66. Company weekly performance is 5.73% while its quarterly performance stands at -30.54%. National Bank of Greece (ADR) (NYSE:NBG) is -71.53% away from its 52 week high.
Quanta Services Inc (NYSE:PWR) reported a shortfall of 578,517 shares or 14.8% in the short interest. The remaining shorts are 1.6% of the total floated shares. The net short interest, as on December 31,2014, stood at 3,331,107 shares and the stocks days to cover will be 1 by factoring in the average per day volume of 2,542,104 shares. On December 15,2014, 3,909,624 shares were shorted. On last trading day Quanta Services, Inc. (NYSE:PWR) increased 2.25% to close at $26.37. Its volatility for the week is 3.52% while volatility for the month is 2.88%. PWR’s sales growth for past 5 years was 11.50% and its EPS growth for past 5 years was 16.50%. Quanta Services, Inc. (NYSE:PWR) monthly performance is 3.29%.
Sprint Corporation (NYSE:S) will release its financial results for the third fiscal quarter of 2014 on Thursday, February 5. The results will be posted atwww.sprint.com/investors at approximately 7:30 a.m. ET. Sprint Corporation (NYSE:S) has 0.10% insider ownership while its institutional ownership stands at 18.20%. In last trading activity company’s stock closed at $4.08.
Shares of Impax Laboratories Inc (NASDAQ:IPXL) have been given a consensus recommendation of “Hold” by the sixteen analysts that are currently covering the stock, StockRatingsNetwork.com reports. One equities research analyst has rated the stock with a sell recommendation, eight have given a hold recommendation and four have given a buy recommendation to the company.On last trading day Impax Laboratories Inc. (NASDAQ:IPXL) increased 2.22% to close at $36.79. Its volatility for the week is 3.82% while volatility for the month is 3.51%. IPXL’s sales growth for past 5 years was 19.50% and its EPS growth for past 5 years was 41.40%. Impax Laboratories Inc. (NASDAQ:IPXL) monthly performance is 26.47%.